<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03416647</url>
  </required_header>
  <id_info>
    <org_study_id>AOPadova</org_study_id>
    <nct_id>NCT03416647</nct_id>
  </id_info>
  <brief_title>SMAS: a Prospective Study in a Single Institution</brief_title>
  <official_title>Superior Mesenteric Artery Syndrome: a Prospective Study in a Single Institution</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera di Padova</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliera di Padova</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Superior Mesenteric Artery Syndrome (SMAS) is a rare cause of duodenal obstruction, that
      should be suspected in cases of chronic, refractory upper digestive symptoms. Between 2008
      and 2016, 39 consecutive patients with chronic gastrointestinal symptoms and a diagnosis of
      SMAS were prospectively included in the study, in order to describe their demographic,
      clinical and outcome features. All patients underwent duodenojejunostomy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2008</start_date>
  <completion_date type="Actual">February 2017</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Symptom score</measure>
    <time_frame>47 months (IQR 34-72)</time_frame>
    <description>Severity (0-6) + frequency (0-5) x 5 symptoms (abd pain, nausea, vomiting, reflux, bloating)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>BMI</measure>
    <time_frame>47 months (IQR 34-72)</time_frame>
    <description>Body mass index</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Need for medical treatment</measure>
    <time_frame>47 months (IQR 34-72)</time_frame>
    <description>PPIs, prokinetic drugs</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">39</enrollment>
  <condition>Superior Mesenteric Artery Syndrome</condition>
  <arm_group>
    <arm_group_label>SMAS patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Duodenojejunostomy</intervention_name>
    <description>Duodenojejunostomy with or without duodenal resection</description>
    <arm_group_label>SMAS patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria (at least 2 of the following):

          -  severe and frequent upper digestive symptoms (occurring at least once a week),
             associated to poor quality of life and refractory response to medical treatment;

          -  a condition of underweight (BMI &lt;18.5 kg/m2) associated with difficulty eating;

          -  severe complications of SMAS (e.g. gastric perforation, acute pancreatitis, aspiration
             pneumonia);

          -  suggestive findings of SMAS at barium swallow;

          -  diagnostic aortomesenteric angle and distance at CT/MR angiography.

        Exclusion Criteria:

          -  inability to provide the informed consent;

          -  malignancies;

          -  bowel motility disorders;

          -  severe psychiatric illness;

          -  pregnancy;

          -  impossibility to perform the required diagnostic workup.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Angelica Ganss, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>General Surgery Unit</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>General Surgery Unit</name>
      <address>
        <city>Padova</city>
        <state>PD</state>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 18, 2017</study_first_submitted>
  <study_first_submitted_qc>January 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 31, 2018</study_first_posted>
  <last_update_submitted>January 24, 2018</last_update_submitted>
  <last_update_submitted_qc>January 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 31, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliera di Padova</investigator_affiliation>
    <investigator_full_name>Angelica Ganss</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Superior Mesenteric Artery Syndrome</keyword>
  <keyword>Chronic duodenal obstruction</keyword>
  <keyword>Duodenojejunostomy</keyword>
  <keyword>Wilkie's syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Superior Mesenteric Artery Syndrome</mesh_term>
    <mesh_term>Mesenteric Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

